BridgeMD
Compares treatment options for Suicidal Ideation
Official title Dynamic Deconstructive Psychotherapy Versus Brief Intervention and Contact for Suicidal Adolescents and Young Adults
ClinicalTrials.gov ID: NCT05988489
What this study is testing
- What it's testing
- The purpose of this clinical trial is to assess whether 6 months of treatment with Dynamic Deconstructive Psychotherapy (DDP) is more effective for reducing thoughts of suicide in suicidal adolescents and young adults than usual care in the community supplemented with Brief Intervention and Contact (BIC). DDP and BIC are two evidence-based practices shown to be more effective than usual care at reducing suicidality.
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 40
You may be able to join if
- CSSRS suicide ideation of ≥ 2 and PHQ-9 item 9 of ≥ 1
- Ages 14 through 40 years old of both genders
- Fluency in English
- Willingness to enter outpatient treatment as evidenced by psychiatric consultation at the PHRP and attending a first session with their intake...
- Willingness to be video-recorded
You likely can't join if
- Previous or current clinical diagnosis of schizophrenia, schizoaffective disorder or autism spectrum disorder as ascertained by self-report on the...
- BMI \< 18 for adults ≥ 18 years old, and BMI \< 17 for adolescents
- Concurrent use of weekly ECT, ketamine, or esketamine
- IQ \< 80 on the Peabody Picture Vocabulary Test
- Current or previous treatment with Dynamic Deconstructive Psychotherapy
See the full eligibility criteria
- CSSRS suicide ideation of ≥ 2 and PHQ-9 item 9 of ≥ 1
- Ages 14 through 40 years old of both genders
- Fluency in English
- Willingness to enter outpatient treatment as evidenced by psychiatric consultation at the PHRP and attending a first session with their intake therapist
- Willingness to be video-recorded
- Completion of baseline outcomes measures
- Previous or current clinical diagnosis of schizophrenia, schizoaffective disorder or autism spectrum disorder as ascertained by self-report on the PHRP intake packet, or on their electronic medical records, or by...
- BMI \< 18 for adults ≥ 18 years old, and BMI \< 17 for adolescents
- Concurrent use of weekly ECT, ketamine, or esketamine
- IQ \< 80 on the Peabody Picture Vocabulary Test
- Current or previous treatment with Dynamic Deconstructive Psychotherapy
The study team makes the final eligibility decision.
Where it's taking place
- Syracuse, New York, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Syracuse, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.